Pharma Aids Limited (DSE:PHARMAID)
Bangladesh
· Delayed Price · Currency is BDT 565.00
+16.80 (3.06%)
At close: Apr 28, 2026
Pharma Aids Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 40.24 | 11.2 | 32.72 | 15.12 | 24.91 | 19.98 | Upgrade
|
| Cash & Short-Term Investments | 40.24 | 11.2 | 32.72 | 15.12 | 24.91 | 19.98 | Upgrade
|
| Cash Growth | 23.29% | -65.78% | 116.46% | -39.30% | 24.68% | 41.86% | Upgrade
|
| Accounts Receivable | 177.49 | 160.91 | 129.58 | 127.1 | 123.51 | 127.23 | Upgrade
|
| Other Receivables | 23.24 | 23.24 | 23.84 | 28.06 | 29.31 | 32.16 | Upgrade
|
| Receivables | 200.73 | 184.16 | 153.43 | 155.16 | 152.82 | 159.4 | Upgrade
|
| Inventory | 62.47 | 63.56 | 61.84 | 56.83 | 63.67 | 39.36 | Upgrade
|
| Prepaid Expenses | - | - | - | - | 14.53 | 7.9 | Upgrade
|
| Other Current Assets | 191.33 | 228.26 | 172.08 | 87.37 | 51.62 | 40.62 | Upgrade
|
| Total Current Assets | 494.78 | 487.17 | 420.07 | 314.48 | 307.54 | 267.25 | Upgrade
|
| Property, Plant & Equipment | 142.93 | 93.77 | 60.12 | 66.86 | 72.27 | 75.4 | Upgrade
|
| Total Assets | 637.71 | 580.94 | 480.19 | 381.34 | 379.82 | 342.65 | Upgrade
|
| Accounts Payable | 3.83 | 3.88 | 5.55 | 1.66 | 1.42 | 0.16 | Upgrade
|
| Accrued Expenses | 52.76 | 42.83 | 38.23 | 29.72 | 32.13 | 23.69 | Upgrade
|
| Short-Term Debt | 16.8 | 27.3 | 18.16 | 11.47 | 0.99 | 0.3 | Upgrade
|
| Current Income Taxes Payable | 81.69 | 68.57 | 73.6 | 50.05 | 33.32 | 14.83 | Upgrade
|
| Other Current Liabilities | 13.48 | 3.81 | 1.75 | 3.44 | 3.34 | 12.68 | Upgrade
|
| Total Current Liabilities | 168.56 | 146.39 | 137.3 | 96.34 | 71.2 | 51.67 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 2.59 | 2.19 | 0.05 | 0.22 | 0.27 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0 | - | - | Upgrade
|
| Total Liabilities | 171.14 | 148.58 | 137.35 | 96.56 | 71.47 | 51.67 | Upgrade
|
| Common Stock | 31.2 | 31.2 | 31.2 | 31.2 | 31.2 | 31.2 | Upgrade
|
| Retained Earnings | 401.61 | 367.4 | 311.65 | 253.58 | 275.56 | 257.09 | Upgrade
|
| Comprehensive Income & Other | 33.76 | 33.76 | - | - | 1.59 | 2.69 | Upgrade
|
| Shareholders' Equity | 466.57 | 432.36 | 342.85 | 284.78 | 308.35 | 290.98 | Upgrade
|
| Total Liabilities & Equity | 637.71 | 580.94 | 480.19 | 381.34 | 379.82 | 342.65 | Upgrade
|
| Total Debt | 16.8 | 27.3 | 18.16 | 11.47 | 0.99 | 0.3 | Upgrade
|
| Net Cash (Debt) | 23.45 | -16.1 | 14.56 | 3.64 | 23.92 | 19.67 | Upgrade
|
| Net Cash Growth | - | - | 299.66% | -84.77% | 21.59% | 118.67% | Upgrade
|
| Net Cash Per Share | 7.51 | -5.16 | 4.67 | 1.17 | 7.67 | 6.31 | Upgrade
|
| Filing Date Shares Outstanding | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | Upgrade
|
| Total Common Shares Outstanding | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | Upgrade
|
| Working Capital | 326.22 | 340.78 | 282.77 | 218.14 | 236.35 | 215.59 | Upgrade
|
| Book Value Per Share | 149.54 | 138.58 | 109.89 | 91.28 | 98.83 | 93.26 | Upgrade
|
| Tangible Book Value | 466.57 | 432.36 | 342.85 | 284.78 | 308.35 | 290.98 | Upgrade
|
| Tangible Book Value Per Share | 149.54 | 138.58 | 109.89 | 91.28 | 98.83 | 93.26 | Upgrade
|
| Land | 36 | 36 | 0.08 | 0.08 | 0.08 | 0.08 | Upgrade
|
| Buildings | 16.67 | 16.16 | 14.29 | 14.29 | 14.29 | 12.57 | Upgrade
|
| Machinery | 249.09 | 195.48 | 193.89 | 193.79 | 191.74 | 188.76 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.